Syndax Pharmaceuticals Inc ($SNDX)
Filing Information
| Accession Number | 0001193125-26-442119 |
|---|---|
| Form Type | 4 |
| Filing Date | Oct 30, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
24,000
Total Value
$208,196.00
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Oct 29, 2026 | Exercise/Conversion | 8,000 | $11.81 | $94,480.00 | 247,763 | Direct | โ | View Details | |
Director | Common Stock | โ | Oct 29, 2026 | Sale | 8,000 | $14.21 | $113,716.00 | 239,763 | Direct | โ | View Details | |
Director | Stock Options (Right to buy) | Derivative | Oct 29, 2026 | Exercise/Conversion | 8,000 | $0.00 | $0.00 | 0 | Direct | โ | View Details |